| - GRCh37:
- Chr1:15788135
- GRCh38:
- Chr1:15461640
| CELA2A | T70M | Abdominal obesity-metabolic syndrome 4 | Pathogenic (May 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:15792640
- GRCh38:
- Chr1:15466145
| CELA2A | | Abdominal obesity-metabolic syndrome 4, Hypertensive disorder, Diabetes, Coronary artery disorder, Hypertriglyceridemia | Pathogenic (Oct 11, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr1:15789253
- GRCh38:
- Chr1:15462758
| CELA2A | L85M | Abdominal obesity-metabolic syndrome 4, Hypertensive disorder, Diabetes, Coronary artery disorder, Hypertriglyceridemia | Pathogenic (Oct 10, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr1:15789885
- GRCh38:
- Chr1:15463390
| CELA2A | D121N | Abdominal obesity-metabolic syndrome 4, Hypertensive disorder, Diabetes, Coronary artery disorder, Hypertriglyceridemia | Pathogenic (Oct 10, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr8:19813360
- GRCh38:
- Chr8:19955849
| LPL | Q262* | Hyperlipoproteinemia, type I, Hypertriglyceridemia, not provided
| Conflicting interpretations of pathogenicity (Jan 22, 2020) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr11:116661656
- GRCh38:
- Chr11:116790940
| APOA5 | Q97* | Cardiovascular phenotype, Hypertriglyceridemia 1, not provided, Hypertriglyceridemia, Familial type 5 hyperlipoproteinemia | Pathogenic (Oct 7, 2022) | criteria provided, multiple submitters, no conflicts |
| | | | Increased blood urea nitrogen, Bronchiolitis, Asthma, Encopresis, Delayed fine motor development, Hypertyrosinemia, Somatic sensory dysfunction, Hypertelorism, Monocytopenia, Abnormal circulating serine family amino acid concentration, Downturned corners of mouthHypertriglyceridemia, Neutropenia, Microdontia, Recurrent otitis media, Thin upper lip vermilion, Eczema, Triangular face, Delayed speech and language development, Frontal bossing, Tall stature, Sleep abnormality, Hyperhydroxyprolinemia, Abnormal emotion, Enuresis, ...see more | Uncertain significance (Aug 20, 2016) | criteria provided, single submitter |
| - GRCh37:
- Chr2:27721143
- GRCh38:
- Chr2:27498276
| GCKR | V103M | not specified, not provided, Fasting plasma glucose level quantitative trait locus 5, Hypertriglyceridemia | Conflicting interpretations of pathogenicity (Oct 20, 2022) | criteria provided, conflicting interpretations |